Close

Valeant Pharma (VRX) Details Compensation for Incoming CEO Papa, Outgoing CEO Pearson

April 28, 2016 6:21 AM EDT Send to a Friend
Valeant Pharma (NYSE: VRX) disclosed teh following late Thursday:Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login